
zzso of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' zzso This focus ignores the value that patients may place on a therapy with a wider zzso of outcomes that offer the potential of a longer period of zzso We call such treatments zzso zzso and contrast them with zzso zzso that offer similar average survival but less chance of a large zzso zzso therapy options do not have these stylized forms, but they can differ in the spread of survival gains that patients zzso We found that 77 percent of surveyed cancer patients with melanoma, breast cancer, or other kinds of solid tumors preferred hopeful gambles to safe zzso This suggests that current technology zzso which often determine access to such cancer therapies, may be missing an important source of value to patients and should either incorporate hope into the value of therapies or set a higher threshold for an acceptable zzso ratio in the zzso zzso 

